# Talus Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/talus-bioscience

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.talus.bio
- Total disclosed funding: $28M
- Latest round: Seed (Jul 29, 2024)
- Investors on record: 8

## About

Based in Washington, US, and founded in 2020 by Alex Federation and Lindsay Pino, Talus Bioscience, Inc. operates as a biotechnology company that is primarily focused on the development of small molecule oncology drugs.

Talus Bioscience, Inc. is a pioneer in drug discovery research that has developed a solution that provides complete information on the drug's effectiveness and selectivity in a single test. The company's platform combines cell manipulation with sensitive quantitative proteomics and advanced machine learning-based analysis. Furthermore, they are working on two projects at the same time to show the potential of their technology in improving gene regulation exploration for drug discovery. Additionally, the firm provides its healthcare sector clients with a valuable tool for advancing gene control drug development.

## Funding rounds

- Seed, Jul 29, 2024, $9.4M — WRF Capital, Y Combinator, NFX, BoxOne Ventures, Two Bear Capital, FundersClub
- Seed, Jun 6, 2022, $9.8M — Y Combinator, FundersClub, NFX, Fifty Years, Boom Capital Ventures
- Seed, Nov 24, 2021, $8.4M — NFX

## Investors

- NFX (https://capitalatlas.ai/funds/nfx) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- FundersClub (https://capitalatlas.ai/funds/fundersclub) — Seed
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Seed
- Boom Capital Ventures — Seed
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Seed
- BoxOne Ventures (https://capitalatlas.ai/funds/boxone-ventures) — Seed
- Two Bear Capital (https://capitalatlas.ai/funds/two-bear-capital) — Seed